Chroman derivatives and uses thereof in the treatment of CNS disorders

Details for Australian Patent Application No. 2005318516 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Krauss, Nancy Elisabeth; Zhao, ShuHai

Agent Spruson & Ferguson

Pub. Number AU-B-2005318516

PCT Pub. Number WO2006/066756

Priority 60/637,792 21.12.04 US

Filing date 13 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 17 February 2011

International Classifications

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 311/68 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/066756 Priority application(s): WO2006/066756

17 February 2011 Application Accepted

  Published as AU-B-2005318516

16 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005318524-Composition suitable for a powder coating composition comprising at least one resin and at least one dispersant

2005318512-Infection-resistant polyurethane foams, method for producing the same and use thereof in antiseptic wound dressings